Unknown

Dataset Information

0

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy.


ABSTRACT: The widespread increase in multiple severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants is causing a significant health concern in the United States and worldwide. These variants exhibit increased transmissibility, cause more severe disease, exhibit evasive immune properties, impair neutralization by antibodies from vaccinated individuals or convalescence sera, and reinfection. The Centers for Disease Control and Prevention (CDC) has classified SARS-CoV-2 variants into variants of interest, variants of concern, and variants of high consequence. Currently, four variants of concern (B.1.1.7, B.1.351, P.1, and B.1.617.2) and several variants of interests (B.1.526, B.1.525, and P.2) are characterized and are essential for close monitoring. In this review, we discuss the different SARS-CoV-2 variants, emphasizing variants of concern circulating the world and highlight the various mutations and how these mutations affect the characteristics of the virus. In addition, we discuss the most common vaccines and the various studies concerning the efficacy of these vaccines against different variants of concern.

SUBMITTER: Ramesh S 

PROVIDER: S-EPMC8537675 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy.

Ramesh Sindhu S   Govindarajulu Manoj M   Parise Rachel S RS   Neel Logan L   Shankar Tharanath T   Patel Shriya S   Lowery Payton P   Smith Forrest F   Dhanasekaran Muralikrishnan M   Moore Timothy T  

Vaccines 20211018 10


The widespread increase in multiple severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants is causing a significant health concern in the United States and worldwide. These variants exhibit increased transmissibility, cause more severe disease, exhibit evasive immune properties, impair neutralization by antibodies from vaccinated individuals or convalescence sera, and reinfection. The Centers for Disease Control and Prevention (CDC) has classified SARS-CoV-2 variants into variants  ...[more]

Similar Datasets

| S-EPMC8848511 | biostudies-literature
| S-EPMC8437313 | biostudies-literature
| S-EPMC8062574 | biostudies-literature
| S-EPMC8669229 | biostudies-literature
| S-EPMC9951973 | biostudies-literature
| S-EPMC9109158 | biostudies-literature
| S-EPMC8008749 | biostudies-literature
| S-EPMC8367776 | biostudies-literature
| S-EPMC8433594 | biostudies-literature
| S-EPMC9843632 | biostudies-literature